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Abstract 
 
  Investigation for immunomodulatory and  
anti-inflammatory mechanisms of mesenchymal stem cells  
on T cells and dendritic cells in CIA mice 
 
Chin Hee Mun 
 
(Directed by Professor Yong-Beom Park) 
 
Mesenchymal stem cells (MSCs) have profound immunomodulatory properties. 
Using their properties, MSCs-based therapies have been applied in several 
inflammatory diseases. The immune modulation of MSCs is related to inhibition of 
proliferation, differentiation, and activation of various immune cells. Dendritic cells 
(DCs) play pivotal roles in initiating immune response as DCs are important antigen-
presenting cells. DCs are able to mature into inflammatory DCs, sustaining a continuous 
activation of adaptive immune system. T cells are critical effector immune cells in 
affecting and regulating immune response to collect signals from DCs. T cells can 
differentiate into one of several subtypes, including TH1, TH2, TH17 or regulatory T cells 
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(Tregs), toward different functional subsets. As the effects of MSCs on DCs and T cells 
have not been fully understood, the immunomodulatory mechanisms of MSCs on DCs 
and T cells were investigated. 
Bone marrow-derived CD11c+ mononuclear cells of DBA/1 mice were differentiated 
cultured with GM-CSF and IL-4, to immature DCs (iDCs) for 6-7 days. CD4+ T cells 
were isolated from spleen of DBA/1 mice by negative selection using CD4+ T cell 
isolation kit. The iDCs were maturated using lipopolysaccharides (LPS), and CD4+ T 
cells were activated under anti-CD3 and anti-CD28 treatment. Human bone marrow-
derived MSCs (BM-MSCs) were co-cultured with mouse DCs and CD4+ T cells directly 
in the different ratios. The effect of BM-MSCs on DC maturation and T cell 
differentiation was assessed by maturation markers by flow cytometry, and supernatants 
for induced production of cytokines were also analyzed. Gene expressions were 
analyzed by quantitative RT-PCR and microarray. In addition, immunohistochemistry 
was performed in inflammatory tissues in collagen-induced arthritis (CIA) mice. 
Human BM-MSCs significantly inhibited the DCs maturation by decreasing CD86 
and major histocompatibility complex (MHC)Ⅱ expressions in both 1:1 and 1:10 co-
culture ratio. BM-MSCs decreased the levels of interleukin (IL)-12p70, tumor necrosis 
factor (TNF)-α, and IL-6 effectively, and increased the levels of IL-10 and transforming 
growth factor (TGF)-β. Also, the relative gene expressions of indoleamine 2, 3-
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dioxygenase (IDO) and heme oxygenase (HO)-1 were increased in 1:1 co-culture ratio 
at 6 hr. As for T cells, the expression of CD4+CD25+FoxP3+ Tregs were highly induced 
in co-culture condition with BM-MSCs. Human BM-MSCs significantly induced the 
CD4+CD25+FoxP3+ Tregs by increasing programmed death-1 (PD-1) and neuropilin-1 
(Nrp-1) expressions, and increased the levels of IL-10 and TGF-β. However, BM-MSCs 
did not induce the FoxP3+ Tregs in the splenic CD4+ T cells from PD-1-/- mice. 
Moreover, immunohistochemical analysis of inflamed tissues in BM-MSC treated CIA 
mice showed significant immunopositive staining for PD-1 on CD4+ T cells. 
The results demonstrate that human BM-MSCs inhibit the maturation of DCs and 
induce anti-inflammatory signals of DCs in in vitro. In addition, these data show that 
human BM-MSCs highly induce the CD4+CD25+Foxp3+ Tregs leading upregulation of 
PD-1 in both in vitro and in vivo. 
 
 
 
 
 
Key words: mesenchymal stem cell, immune modulation, dendritic cell, regulatory T 
cell 
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of mesenchymal stem cells on T cells and dendritic cells in CIA mice 
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Department of Medical Science 
The Graduate School, Yonsei University 
 
(Directed by Professor Yong-Beom Park) 
 
 
Ⅰ. INTRODUCTION 
Mesenchymal stem cells (MSCs) are multipotent progenitor cells that can differentiate 
into tissues of mesenchymal lineage, including bone, cartilage, and adipose tissue. Most 
studies of MSCs have focused on the regenerative properties of the cells; however, 
MSCs also have unique immunoregulatory properties1-3. MSCs have potent 
immunoregulatory effects that might be mediated through direct cell-to-cell contact or 
secretion of soluble factors. The relative ease of harvesting MSCs and their stable 
phenotype in culture make the cells an attractive tool for cellular therapy in 
alloimmunity, autoimmunity, and inflammation. This phenomenon has led to an 
increasing number of clinical trials, such as in graft-versus-host disease, Crohn’s disease, 
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and multiple sclerosis4,5. 
Mesenchymal stem cells have intermediate levels of HLA major histocompatibility 
complex (MHC) class I molecules, but do not have HLA class II antigens, FAS ligand, 
and the co-stimulatory molecules3,4. Several articles indicate that T-cell proliferation 
induced with specific antigens or polyclonal mitogens and allogeneic cells is inhibited 
by MSCs6-8. However, the induction of immune responses is a complicated interaction 
between T cells and DC, and it has been shown that MSC have inhibitory effects on DC 
9-11. However, the precise immunosuppressive mechanisms employed by MSC are not 
well understood. 
T cells play important roles in affecting and regulating immune response as T cells are 
critical effector immune cells. T cells can differentiate into one of several subtypes, 
including TH1, TH2, TH17 or regulatory T cells (Tregs), toward different functional 
subsets. Recently, human MSCs induced Foxp3+ Tregs population in inflammatory 
disease of animal models according to previous reports10-12. However, the 
immunomodulatory mechanisms of MSCs on Tregs induction remain unclear.  
Dendritic cells (DCs) play pivotal roles in initiating immune response as DCs are 
important antigen-presenting cells13. DCs are able to mature into inflammatory DCs, 
sustaining a continuous activation of adaptive immune system. Human MSC decreased 
the maturation of DCs in vitro previously10,11. However, the effects and mechanisms of 
MSCs on DC maturations and function have not been fully understood.  
In this study, it was investigated the immunomodulatory property of MSCs on DCs 
maturation and differentiation and the immunosuppressive mechanisms of MSCs on 
helper T cells and Tregs in collagen-induced arthritis (CIA) mice in in vitro and in vivo. 
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Ⅱ. MATERIALS AND METHODS 
1. Animals 
All procedures involving animals were carried out in accordance with the Laboratory 
Animals Welfare Act, the Guide for the Care and Use of Laboratory Animals, and the 
Guidelines and Policies for Rodent Experiments provided by the Institutional Animal 
Care and Use Committee of Yonsei University Health System, Seoul, Korea. Approval 
by our institutional review board was obtained (2013-0014-1 and 2010-0372-1, Yonsei 
University, College of Medicine, Seoul, Korea). 
 
2. Culture of human bone marrow derived-mesenchymal stem cells (hBM-MSCs) 
All frozen stocks of MSCs were provided at passage 1 or 2 by the Cell Therapy Center, 
Severance Hospital (Yonsei University, College of Medicine, Seoul, Korea) after 
obtained with donor consent. Cells were plated at a density of 1×106 cells per 10-cm 
cell culture dish (BD Biosciences) with Dulbecco’s modified Eagle medium (low 
glucose) supplemented with 10% fetal bovine serum, 1% glutamine, 1% non-essential 
amino acids, 0.01% 2-mercaptoethanol, and 1% penicillin-streptomycin (all from 
Invitrogen). MSCs were cultured at 37°C in an atmosphere containing 5% CO2, and the 
medium was changed every 3–4 days. All MSCs were cultured until passage 5-6, 
harvested, and stored in liquid nitrogen until use.  
 
3. CD11c+ dendritic cells (DCs) and CD4+ T cell isolation and co-culture with hBM-
MSCs 
Bone marrow-derived CD11c+ mononuclear cells of DBA/1 mice (at 6 wk) were 
cultured in the presence of GM-CSF and IL-4 to immature DCs (iDCs) for 7 days. The 
iDCs were maturated using lipopolysaccharides (LPS). Human BM-MSCs and mouse 
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DCs were co-cultured directly with 1:1 and 1:10 ratio. CD4+ T cells were isolated from 
spleen of DBA/1 mice (at 6 wk) by negative selection using CD4+ T Cell isolation kit 
Ⅱ (Miltenyi Biotech, German) and then purified CD4+ T cells were cultured in 
complete RPMI medium containing 10 % of heat-inactivated FBS, 20 mM HEPES, 1 
mM sodium pyruvate, 100 U/ml penicillin, 100 ug/ml streptomycin, 1 mM non-essential 
amino acids, 20 ug/ml Gentamycin and 500 uM β-mercaptoethanol. CD4+ T cells were 
cultured alone or added at the ratio 1:5 , 1:20, 1:100 in 12 well plate which is coated 
1x105 hBM-MSCs and stimulated with 2 ug/ml anti-mouse CD3e/CD28 (BD pharmigen) 
for 24, 48, 72 hr, and then cell pellet stored at deep freezer still used. 
 
4. Fluorescence activated cell sorting (FACS) 
After 6, 18, 24, 48 and 72hr of culture, DC were obtained and after 72hr of culture, 
CD4+ T cells were obtained at stimulation for 5 hr with 50 ng/ml phorbolmyristate 
acetate (PMA) and 750 ng/ml Ionomycin and 1 ug/ml Golgi plug. For cell surface 
antigen stainings, DC and CD4+ T cell were stained by the appropriate antibodies were 
added and incubated in 100ul suspension for 30 min at 4 ℃. After washing steps, we 
performed intracellular staining. For that purpose, CD4+ T cells were fixed and 
permeabilized by Foxp3 Fixation/Permeabilization working solution for 60 min in the 
dark at 4 ℃. After washing appropriate antibodies were added for Foxp3 staining and 
incubated in 100ul suspension for 30 min at 4 ℃. The following antibodies were used 
for T cell experiments: CD4-FITC (clone RM4-5, Ca: 553047, BD Pharmigen), CD25-
PerCP (clone PC61, Ca: 551071, BD Pharmigen), IFN-r-PE (Ca: 554412, BD 
Pharmigen), IL-4-PerCP (clone 11B11, Ca: 560700, BD Pharmigen), IL-17A-PE (Ca: 
559502, BD Pharmigen), PD-1-APC (clone J43, Ref: 17-9985-80, eBioscience) and 
Nrp-1-PE/Cy7 (clone 3E12, Ca: 145212, Biolegend), FoxP3-PE (eBioscience). The 
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following antibodies were used for DC experiments: CD11C-APC (clone HL3, Ca: 
550261, BD Pharmigen), CD86-PE (clone GL1, Ca: 553692, BD Pharmigen) and MHC
Ⅱ-FITC (clone 2G9, Ca: 553623, BD Pharmigen). Cells were analyzed on FACS Verse 
(BD Pharmigen). Data was analyzed by FlowJo Ver10. 
 
5. Enzyme-linked immunosorbent assays (ELISAs)  
DC and T cells were co-culture with MSC at the different ratio or without MSC, 
supernatants were collected on 24, 48, and 72hr. And the amounts of secreted cytokines 
including murine IL-12p70, IL-6, TNF-α, IL-10 and TGF-β1 in the supernatants were 
measured using an ELISA kit (eBioscience, BD Pharmigen) according to 
manufacturer’s instructions. 
 
6. RT-PCR and real-time PCR 
RNA was isolated using GeneJET RNA purification kit (#K0731, Molecular Biology), 
and RNA concentration was determined using a Nano-DropND1000 spectrophotometer 
(Labtech International, East Sussex, UK). And cDNA was synthesized using Maxime 
RT PreMix (iNtRON, Ca: 25081) as follows: an initial denaturation step (at 94℃ for 3 
min), 35 cycles of PCR (95℃ for 30 s, 50℃ for 30 s, 72℃ for 15 s) then a final step 
at 72℃ for 10 min, using the SimpliAmpTM Thermal cycler (Applied Biosystems, 
Weiterstadt, Germany). Real-time PCR was performed on an ABI Systems 7500 Fast 
machine (Applied Biosystems, Weiterstadt, Germany) by using qPCRBIO syGreen Mix 
Hi-ROX purchased from PCRBIOSYSTEMS, according to the manufacture’s 
recommendations. Amplification conditions were 95℃ for 30 s, followed by 40 cycles 
at 95℃ for 5 s and 60℃ for 30 s. Relative transcript expression was normalized against 
GAPDH transcript, where Δ cycle threshold represents the difference in the cycle 
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threshold values between the target gene and the housekeeping gene. The resulting cycle 
threshold (Ct) value was processed based on the comparative Ct method, where gapdh 
was used as an endogenous reference gene to normalize the expression level of other 
genes. Primer sequences for detection of ctla-4, foxp3, pd-1 and several genes were 
previously published and as follows (Table 1). 
 
 
 
Table 1. The real time PCR primer sequences 
 forward reverse 
T-bet CAACCAGCACCAGACAGAGA ACAAACATCCTGTAATGGCTTG 
Rorγ-t CAAATACGGTGGTGTGGAG ACGGTTGGCATTGATGAG 
Gata-3 TGACGGAAGAGGTGGACG CTGGCTCCCGTGGTGG 
Pd-1 TTCAGGTTTACCACAAGCTGG TGACAATAGGAAACCGGGAA 
Nrp-1 GAAGGCAACAACAACTATGA ATGCTCCCAGTGGCAGAATG 
Ctla-4 ACCCCTCACAATCACTGTCC CACCTGCAGGAAGAACTGGT 
Lag-3 TCCGCCTGCGCGTCG GACCCAATCAGACAGCTTGAGGAC 
Tgf-β1 AGCAGTGCCCGAACCCCCAT GGGGTCAGCAGCCGGTTACC 
Il-10 AATAAGAGCAAGGCAGTG CCAGCAGACTCAATACAC 
Ido GTACATCACCATGGCGTATG CGAGGAAGAAGCCCTTGTC 
Ho-1 CTGCTAGCCTGGTGCAAGATACT GTCTGGGATGAGCTAGTGCTGAT 
Pd-l1 GCTGAAGTCAATGCCCCATA TCCACGGAAATTCTCTGGTTG 
Icos TGA CCC ACC TCC TTT TCA AG TTA GGG TCA TGC ACA CTG GA 
Gapdh GTGTTCCTACCCCCAATGTGT ATTGTCATACCAGGAAATGAGCTT 
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7. Western blot analysis 
Cells were collected at 24, 48 and 72 hr and stored at deep freezer for western blot 
analysis. Procedures for extraction of cellular proteins, T cells were lysed in RIPA Buffer 
(Lot#R0214711K) with protease inhibitor cocktail tablet (Roche) for 30 min on ice and 
then using a sonicator for completed lysis. The protein concentrations were measured 
using the Pierce™ BCA Protein Assay Kit (Ca: 23225 Thermo Scientific) and equalized 
protein samples were used for the electrophoresis. The proteins were then transferred to 
polyvinylidene difluoride (PVDF) membrane. The PVDF membranes were blocked in 
5% non-fat milk in Tris buffered solution (TBS) for 1 hr. After washing steps, incubated 
with anti-mouse antibodies during overnight at 4℃, including PD-1, NRP-1, Foxp3 and 
β-actin at dilutions (1:2,000). The membrane was washed three time with TBS and 
incubated with appropriate different secondary antibodies (1:3,000), goat anti- rabbit 
IgG-HRP (Lot # H0614), donkey anti- goat IgG-HRP (Lot # H2113), goat anti-rat IgG-
HRP (Lot # E2313), goat anti-mouse IgG-HRP (Lot # G1213) from Santa Cruz 
Biotechnology. The immunoreactivity was determined using an ECL Western Blotting 
Substrate (REF W1001, Promega) and then exposure Las 4000. Then, the relative band 
density of the target protein to β-actin was quantified with image J. 
 
8. T cell proliferation assay 
CD4+ T cells were prepared and cultured in 12-well plates (5 × 105 cells/well) in 
presence of hBM-MSC (1 × 105 cells/well) for 72 hr. T cells were stained with 5 mM 
carboxyfluorescein diacetate succinimidyl ester (CFSE; eBioscience). Anti-CD3/CD28 
antibodies (5 ug/ml; BD Biosciences, San Jose, CA, USA) were suspended in RPMI 
1640 (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen) as stimulator. 
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Proliferation was measured by the reduction in the CFSE concentration using flow 
cytometry (FACS Verse, BD). 
 
9. Inhibitor study 
CD4+ T cells were isolated from spleen of PD-1 knockout mice provided from Dr. Sang-
Jun Ha (Yonsei University) to determine the involvement of PD-1 to induce Foxp3+ 
Tregs in this study. CD4+ T cells were cultured alone or added at the ratio 1:5 in 12 well 
plate which is coated 1x105 hBM-MSCs and stimulated with 2 ug/ml anti-mouse 
CD3e/CD28 (BD pharmigen) for 72 hr, and then the expression of Foxp3+ Tregs was 
analyzed by FACS (FacsVerse, BD Pharmigen). 
  
10. DC function assays 
5 x 105 DCs were co-cultured with MSCs in 12-well flat-bottomed plates for 6 hr. Then, 
CFSE labeled-CD4+ T cells were added at 1:10 ratio (DC: T) in MSC-DC co-cultured 
plates for 72hr. Proliferation of CD4+ T cells and Tregs expression were measured by 
flow cytometric analysis. 
 
11. Microarray 
750 ng of labeled cRNA samples were hybridized to each Mouse WG6 expression v.2 
bead array for 16-18 hr at 58°C, according to the manufacturer's instructions (Illumina, 
Inc., San Diego, USA). Detection of array signal was carried out using Amersham 
fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) 
following the bead array manual. Arrays were scanned with an Illumina bead array 
Reader confocal scanner according to the manufacturer's instructions.  
The quality of hybridization and overall chip performance were monitored by visual 
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inspection of both internal quality control checks and the raw scanned data. Raw data 
were extracted using the software provided by the manufacturer (Illumina 
GenomeStudio v2011.1 (Gene Expression Module v1.9.0)). Array probes transformed 
by logarithm and normalized by quantile method. 
Statistical significance of the expression data was determined using LPE test and fold 
change in which the null hypothesis was that no difference exists among groups. False 
discovery rate (FDR) was controlled by adjusting p value using Benjamini-Hochberg 
algorithm. For a DEG set, Hierarchical cluster analysis was performed using complete 
linkage and Euclidean distance as a measure of similarity. Gene-Enrichment and 
Functional Annotation analysis for significant probe list was performed using DAVID 
(http://david.abcc.ncifcrf.gov/home.jsp). All data analysis and visualization of 
differentially expressed genes was conducted using R 3.0.2 (www.r-project.org). 
 
12. Induction of CIA 
Male DBA/1J mice (8 wk old; Central Lab Animal, Inc., Seoul, Korea) were injected 
intradermally at the base of the tail with 200 µg bovine type II collagen (CII; Chondrex, 
Redmond, WA, USA) emulsified in Freund’s complete adjuvant (1:1, v/v; Chondrex) 
containing 200 µg Mycobacterium tuberculosis H37Ra (Chondrex). 2 wk later the mice 
were given intradermal booster injections of 100 µg CII in incomplete Freund’s 
adjuvant (1:1, v/v; Chondrex). Mice were monitored twice weekly for signs of arthritis 
based on paw swelling and arthritis scores14. Clinical arthritis was scored on a scale of 
0–4. Each paw was graded and the grades were summed to yield the arthritis score for 
each animal (maximum possible score, 16). Arthritis scoring was performed by two 
independent observers. Mice were randomly distributed to each treatment group (n=5) 
at 1 wk after 2nd booster injection of CII when arthritis scores were between 4 and 6.  
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13. Treatment protocol for CIA 
Treatment was begun after the onset of disease, when arthritis had become well 
established, approximately 3 wk after the primary immunization, and clinical 
assessment was continued for following 4 wk. CIA mice were injected intraperitoneally 
daily with 100 μl phosphate-buffered saline (PBS control, n=5; Invitrogen, Carlsbad, 
CA, USA) and 100 μl PBS containing 2.5×106 BM-MSCs twice over a 3-day interval 
(total 5×106 cells, n=5 per each group). To compare therapeutic efficacy, treatment-
control mice (n=5) were injected intraperitoneally with 35 mg/kg methotrexate (MTX) 
twice weekly for 4 wk. To assess time-dependent changes in therapeutic responses, 
twenty mice were enrolled, and five mice were sacrificed according to the experimental 
schedule every week. Finally, all mice were sacrificed 28 days after final MSC injection. 
The serum, lymph nodes, spleen, and limbs of all animals were collected for analysis. 
 
14. Histological and immunohistochemical assessments of CIA 
At day 28 from final MSCs injection, mice were anesthetized with a standard dose of 
Zoletil (Virbac, Carros, France) and Rompun (Bayer, Barmen, Germany) and 
euthanized for analysis. Formalin (10%, Merck & Co. Inc, NY, USA)-fixed limbs were 
decalcified in formic acid (5 %, Sigma) for 2-3 wk and embedded in paraffin. Serial 4-
μm sections were cut and stained with specific antibodies directed against murine tumor 
necrosis factor-α (TNF-α; 1:500; Hycult Biotechnology, Uden, Netherlands), 
interleukin (IL)-1β (1: 500, Santa Cruz Biotechnology, Santa Cruz, CA, USA), IL-6 (1: 
250, Santa Cruz Biotechnology), IL-10 (1:1,000; Abcam, Cambridge, UK) and 
programmed cell death (PD)-1 (1:500, Biolegend) followed by horseradish peroxidase-
conjugated secondary antibodies and staining with diaminobenzidine (DAKO, Glostrup, 
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Denmark). Antigen retrieval process was done by microwave oven heating and enzyme 
digestion using protease (Sigma-Aldrich) before the application of the primary 
antibodies. Expression of markers in the synovial tissues of paw and knee joints was 
scored semiquantitatively on a four-point scale (0-3) independently by two blinded 
observers, and the average scores were calculated15. 
 
15. Confocal microscopy 
Nonspecific binding was blocked with 1% normal goat serum in PBS with Tween-20 
(Sigma-Aldrich) for 30 min. The sections were incubated with goat anti-mouse CD3 
(1:500; Abcam) and rat anti-mouse PD-1 (1:500; Biolegend) at 4 ℃ for overnight, 
washed 3 times with PBS, incubated with Alexa Fluor 488-labeled donkey anti-goat 
IgG and Alexa Fluor 568-labeled donkey anti-rat IgG (each 1:200; Invitrogen) at room 
temperature for 1 h, and washed 3 times with PBS. All sections were mounted in a 
mounting medium (Vector Laboratories) and examined under a laser scanning confocal 
microscope (LSM 700; Carl Zeiss). Two pathologists independently assigned 
semiquantitative scores for the intensity and distribution of immunofluorescence 
staining for IgG and C3, on a scale ranging 0 - 3 for staining intensity, in which 0 = no 
staining, 1 = weak staining, 2 = moderate staining, and 3 = strong staining. The average 
score from the 2 pathologists was calculated. 
 
16. Tregs suppression assay 
To measure the suppressive capacity of Tregs generated in the presence of MSCs, 
CD4+CD25+ Tregs and CD4+ T cells were isolated from spleens and stained with 5 mM 
carboxyfluorescein diacetate succinimidyl ester (CFSE; eBioscience). Anti-CD3/CD28 
antibodies (5 ug/ml; BD Biosciences, San Jose, CA, USA) were suspended in RPMI 
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1640 (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen) as stimulator. 
CD4+ T cells were co-cultured with CD4+CD25+ Tregs at a ratio of 10:1 (1×105 CD4+: 
1×104 CD4+CD25+). Suppression of T-cell proliferation was measured by the reduction 
in the CFSE concentration using flow cytometry (FACS caliber, BD). 
 
17. Statistics 
All values represent the mean ± standard deviation (SD) or standard error of mean (SEM) 
for various experimental groups. Statistical analysis was performed using an unpaired 
Student t test for comparision between two groups or by a one- or two-way analysis of 
variance (ANOVA), mixed linear tests (GraphPad Prism 5) followed by a Bonferroni 
correction for multiple comparisions. P values of P <0.05 (*), P <0.01 (**) or P < 0.001 
(***) were considered statistically significant. 
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Ⅲ. RESULTS 
 
Part 1. Immune modulation of hBM-MSCs on T cells 
 
1. hBM-MSCs reduced expression of IL-1β, IL-6, and TNF-α and increased 
expression of IL-10 in inflamed joints of CIA mice 
Immunohistochemical analysis of paw and knee joint tissue in untreated CIA mice 
showed significant immunopositive staining for IL-1β, IL-6, and TNF-α that was 
localized primarily in synovium. IL-1β, IL-6, and TNF-α staining were decreased in 
MSC-treated mice compared to untreated mice. IL-10 expression was significantly 
induced in hBM-MSC-treated mice (Fig. 1A-B). 
 
Figure 1. Immunohistochemical analysis of inflammatory cytokines in the joints of CIA 
mice. IL-1β, IL-6, and TNF-α were highly expressed in the joints of untreated CIA mice. 
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IL-10 expression was significantly induced in MSC-treated mice. (A) Inflamed tissue 
were collected from untreated mice, mice treated with hBM-MSCs. (B) Immonopositivity 
was scored semi-quantitatively on a scale ranging 0 – 3 for staining intensity. All values 
are the mean ± SD. All scale bars = 200 um. *, p < 0.05 versus untreated CIA mice (n=5 
per each group). 
 
2. hBM-MSCs induced Tregs expression in mice with CIA  
To investigate Tregs expression, the proportion of Tregs in lymph node and spleen of 
CIA mice at different time points after administration of hBM-MSCs. The induction of 
Tregs was significantly increased in lymph node (A) and spleen (B) of mice treated with 
5×106 BM-MSCs (Fig 2). In addition, the induction of Tregs was significantly increased 
2 wk after treatment (A-C), when the clinical arthritis scores began to improve and 
changes were seen in levels of the anti-inflammatory cytokines IL-10 and TGF-β. 
 
Figure 2. Induction of Tregs treated by hBM-MSCs in mice with CIA. Expression of 
Tregs was significantly increased in lymph nodes (A) spleen (B) of CIA mice 2 wk after 
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treatment with 5 x 106 hBM-MSCs, when the clinical scores ad levels of anti-
inflammatory cytokine IL-10 began to improve (published data). Results of glow 
cytometric analysis are shown in (C). Values are the mean ± SD. *, p < 0.05 versus 
untreated CIA mice (n=5 per each group). 
 
3. Tregs suppressive activity by hBM-MSCs treatments 
To identify the activity of Tregs induced by BM-MSCs treatment, the functionality of 
Tregs was assessed using an in vitro Treg suppression assay. Tregs showed potent 
suppressive activity, through inhibition of T-cell proliferation in the hBM-MSCs-treated 
group compared to untreated CIA mice (Fig. 3).  
 
Figure 3. Treg suppressive activity. Treg suppression assay showed that Treg suppressive 
activity in hBM-MSC-treated mice compared to untreated CIA mice (n=5 per each group). 
Red line of square box represents Treg only group, and blue line represents the 
proliferation of CD4+ T cells. CFSE, carboxyfluorescein diacetate succinimidyl ester. 
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4. hBM-MSCs increased the proliferation of CD4+T cells in co-culture condition 
To investigate the effect of hBM-MSCs for regulation of CD4+ T cell population, 
proliferation assay was done using CFSE staining. CD4+ T cells were co-cultured with 
hBM-MSCs in 1:5 (MSC: T) ratio for 72 hr. hBM-MSCs increased T cell proliferation 
compared to CD4+ T cell only (Fig. 4).  
 
Figure 4. Proliferation activity of CD4+ T cell co-cultured with hBM-MSCs. hBM-MSCs 
increased the proliferation of CD4+ T cells. CFSE labeled-CD4+ T cells were analyzed 
by FACS (n=3). CFSE, carboxyfluorescein diacetate succinimidyl ester; MFI, median 
fluorescence intensity; 1:5, co-culture ratio of MSC:T. 
 
5. hBM-MSCs decreased Th1, Th17, and Th2 responses 
To examine whether MSCs has an effect on the inhibition of Th1, Th1, and Th2 
differentiation, CD4+ T cells were co-cultured with BM-MSCs in 1:5 (MSC: T) ratio for 
72 hr. hBM-MSCs decreased the proportion of CD4+ IFN-r+ T cells for Th1, CD4+ IL-
17A+ T cells for Th17, and CD4+ IL-4+ T cells for Th2 (Fig. 5A-C). Also, the gene 
expressions of T-bet, RORr-T, and Gata-3, which are transcription factors for Th1, Th17, 
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and Th2 respectively were decreased in co-culture with hBM-MSCs (Fig. 5D-F). 
 
Figure 5. Alteration of T cells population by BM-MSCs. hBM-MSCs decreased the 
expressions of T-bet (Th1), RORγ-T (Th17), and Gata-3 (Th2) of T cell population. (A-
C) CD4+ T cells were isolated from mice and stimulated with anti-CD3 and anti-CD28 
for 72 hr. The cells were restimulated with PMA and Ionomycin for 5 h in the presence 
of GolgiPlug, and then analyzed by intracellular flow cytometry staining to determine the 
distribution of CD4+ T cells positive for IFN-γ, IL-17A, and IL-4. (D-F) Relative Gene 
expressions of T cell subset. Values are the mean ± SD. *, p < 0.05 versus CD4+ T cells 
only (n=4). 
 
6. hBM-MSCs increased the expression of CD4+CD25+FoxP3+ Tregs in in vitro 
To examine whether hBM-MSCs has an effect on the propotion of Tregs differentiation, 
CD4+ T cells were also co-cultured with hBM-MSCs at different ratios for 72 hr. hBM-
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MSCs increased the proportion of CD4+CD25+FoxP3+ Tregs in a dose dependent manner 
of co-culture ratios (Fig. 6).  
 
Figure 6. Increase of CD4+CD25+FoxP3+ Tregs co-cultured with hBM-MSC. MSC 
increased the expression of FoxP3+ Tregs in a dose-dependent manner. (A-C) CD4+ T 
cells were isolated from mice and stimulated with anti-CD3 and anti-CD28 for 72 hr. The 
cells were restimulated with PMA and Ionomycin for 5 h in the presence of GolgiPlug, 
and then analyzed by intracellular flow cytometry staining to determine the distribution 
of CD4+ T cells positive for FoxP3. Values are the mean ± SD. *, p < 0.05 versus CD4+ 
T cells only (n=5). 
 
7. hBM-MSCs increased levels of TGF-β1 and IL-10 in co-cultured supernatant 
To elucidate the mechanism of Foxp3+ Tregs induced by MSCs, the two major anti-
inflammatory cytokines were measured from co-cultured supernatant with BM-MSC 
after 24, 48, and 72hr. The anti-inflammatory cytokines TGF-β1 and IL-10 were 
significantly increased in all co-culture groups at all time points compared to CD4+T 
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cell only (Fig. 7A-B), and gradually increased in a time dependent manner. Also, the 
level of TGF-β1 was almost 2 times that of IL-10 at 24hr co-culturing with BM-MSC 
on CD4+ T cells.  
 
Figure 7. Time-dependent changes in levels of anti-inflammatory cytokines. Expressions 
of TGF-β1 and IL-10 were significantly increased in all co-culture groups with hBM-
MSCs. (A) TGF-β1 and (B) IL-10 levels were assessed in co-cultured supernatant with 
MSCs on CD4+ T cells. Values are the mean ± SD. ***, p < 0.001 versus CD4+ T cells 
only (n=5), ns means not significant. 
 
8. hBM-MSCs induced PD-1 gene expression of CD4+ T cells   
To investigate the mechanisms that induce Foxp3+ Tregs, real time qPCR was 
performed for several immunoreceptors of CD4+ T cells. Gene expression of 
programmed cell death 1 (PD-1) was increased in a time dependent manner in 1:5 (MSC: 
CD4 T) ratio (Fig. 8A). In addition, BM-MSC significantly increased gene expression 
of Neuropilin-1 (Nrp-1) at 24hr (Fig. 8B), but decreased gene expressions of 
CD28/cytotoxic T lymphocyte antigen 4 (CTLA-4) and lymphocyte activation gene-3 
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(LAG-3) in a time dependent manner though were not significant (Fig. 8C-D). Gene 
expressions of TGF-β1 and IL-10 were also increased as well as protein levels compared 
to CD4+ T cells only without hBM-MSCs (Fig. 8E-F). 
 
Figure 8. Changes of gene expressions of CD4+ T cells by BM-MSC. BM-MSC 
significantly increased gene expressions of PD-1, Nrp-1, TGF-β1, and IL-10. (A-D) 
Relative gene expressions of PD-1, Nrp-1, CTLA-4, and LAG-3. Each experiment was 
conducted in triplicates. (E-F) Relative gene expressions of TGF-β1 and IL-10. Each 
experiment was conducted in triplicates. Values are the mean ± SD. *, p < 0.05 and ***, 
p < 0.001 versus CD4+ T cells only as control of each time points (n=5). 
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9. PD-1+ Tregs were highly induced by hBM-MSCs 
As well as gene expression, the surface expression of PD-1 of CD4+Foxp3+ Tregs was 
examined using FACS markers. The expression of CD4+CD25+FoxP3+ PD1+ Tregs 
were highly induced in co-culture condition compared to CD4+ T cells only. And PD-1 
expression was increased in a dose dependent manner in co-culture condition with BM-
MSCs (Fig. 9). 
 
Figure 9. PD-1+ Tregs expression. hBM-MSCs increased CD4+CD25+FoxP3+ PD-1+ 
Tregs expression in co-culture condition compared to CD4+ T cells only. (A) Frequency 
of FoxP3+ PD-1+ Tregs and (B) absolute number of FoxP3+ PD-1+ Tregs co-cultured with 
BM-MSCs for 72 hr. Values are the mean ± SD. *, p < 0.05 versus CD4+ T cells only 
(n=5). 
 
10. hBM-MSCs increased the protein expressions of Foxp3, PD-1 and Nrp-1  
To examine the roles of Foxp3, PD-1 and Nrp-1, protein expressions were evaluated 
by immunoblot. Human BM-MSC increased the protein level of FoxP3 (A), PD-1 (B) 
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and Nrp-1 (C) of CD4+ T cell in MSC: T (1:5) co-culture condition (Fig. 10). 
 
 
Figure 10. Increased expression of Foxp3, PD-1 and Nrp-1 proteins by hBM-MSCs. (A) 
Western blot and (B-D) densitometric data of FoxP3, PD-1, and Nrp-1. Values are the 
mean ± SD. *, p < 0.05 versus CD4+ T cells only (n=4). 
 
11. PD-1 is required for Tregs induction by hBM-MSCs 
To evaluate the role of PD-1 toward FoxP3+Tregs induction by hBM-MSCs, PD-1 
inhibition was conducted by treating PD-1 neutralizing antibody (20 ug/ml, Peprotech) 
into MSC-T cells co-culturing media for 72 hr. The expression of FoxP3+Tregs was not 
increased when co-cultured with MSC (1:5 ratio) treated with PD-1 neutralizing antibody 
(Fig. 11). According to data, FoxP3+Tregs induction by hBM-MSCs might be dependent 
on PD-1 expression of CD4+ T cells.  
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Figure 11. Effect of FoxP3+ Tregs expression using PD-1 neutralizing antibody in vitro. 
FoxP3+Tregs expression was not increased when co-cultured with BM-MSC treated with 
PD-1 neutralizing antibody. Splenocytes were isolated from mice and stimulated with 
anti-CD3 and anti-CD28 for 72 hr. The cells were restimulated with PMA and Ionomycin 
for 5 hr in the presence of GolgiPlug or GolgiStop, and then analyzed by intracellular 
flow cytometry staining to determine the distribution of CD4+ T cells positive for Foxp3.  
 
12. PD-1 is critical for Tregs induction by BM-MSCs in PD-1 knockout mice 
Next, to confirm the role of PD-1 inducing Foxp3+ Tregs, the CD4+CD25+FoxP3+ Tregs 
expression was assessed in splenic CD4+ T cells of PD-1-/- mice. According to data, 
Foxp3+ Tregs were increased in co-culture with BM-MSCs for 72 hr compared to without 
MSC in wildtype mice. However, Foxp3+ Tregs expression was not increased in co-
culture with BM-MSCs and CD4+ T cells isolated from spleen of PD-1-/- mice (Fig. 12).  
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Figure 12. Effect of FoxP3+ Tregs expression in PD-1 knockout mice. (A) Foxp3+ Tregs 
expression was not increased in co-culture with BM-MSCs and CD4+ T cells isolated 
from spleen of PD-1-/- mice. (B) Quantitative analysis of CD4+CD25+FoxP3+ Tregs in 
spleen of WT and PD-1-/- mice. Splenic CD4+ T cells were isolated from PD-1-/- mice and 
stimulated with anti-CD3 and anti-CD28 for 72 hr with or without hBM-MSCs. The cells 
were restimulated with PMA and Ionomycin for 5 hr in the presence of GolgiPlug or 
GolgiStop, and then analyzed by intracellular flow cytometry staining to determine the 
distribution of CD4+ T cells positive for Foxp3. WT, wild type mice. 
 
13. PD-1 expression was increased in hBM-MSCs-treated CIA mice 
Treatment with hBM-MSC attenuated the severity of arthritis significantly during the 
progression of CIA. In addition, human BM-MSC treated CIA mice showed significant 
immunopositivity for PD-1 on T cells (Fig. 13). 
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Figure 13. Immunohistochemical analysis of inflamed tissues in CIA mice. hBM-MSC 
treated CIA mice showed significant immunopositivity for PD-1 on T cells (A) Laser 
scanning confocal microscopy was used to assess the intensity and distribution of 
immunofluorescence staining for DAPI (blue) and PD-1 (red) and (B) 
immunofluorescence staining for CD3 (green) and PD-1 (red) in the inflamed tissue 
from untreated CIA mice, mice treated with BM-MSCs.  
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Part 2. Immune modulation of hBM-MSCs on DC 
 
14. Inhibition of CD86 and MHCⅡ expressions on DC by hBM-MSCs 
To examine the effects of hBM-MSCs on DC maturation, the expressions of CD86 and 
MHCⅡ were assessed by FACS analysis. The surface expressions of CD86 and MHC
Ⅱ highly induced under LPS (100 ng/ml) treatment. But, co-culture in the presence of 
hBM-MSCs resulted in decreased expression of CD86 (Fig. 14A-B) and MHCⅡ (Fig. 
15A-B) in both 1:1 and 1:10 co-culture ratio in different time windows. Activation of 
immature DCs by LPS in the presence of MSCs did not result in upregulation of 
costimulatory molecules. 
 
Figure 14. Inhibition of CD86 expression on DC co-cultured with hBM-MSCs. BM-
MSCs decreased CD86 expression in both 1:1 and 1:10 co-culture ratio. (A) Flow 
cytometry plots showing percentages of CD11c+ and CD86+ DC in murine DC co-
cultured with hBM-MSC. (B) Quantification of CD86 expression. Values are the mean ± 
SD. **, p < 0.01 and ***, p < 0.001 versus LPS treated DC (n=5). ns, not significant. 
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Figure 15. Inhibition of MHCⅡ expressions on DC co-cultured with hBM-MSCs. BM-
MSCs decreased of MHCⅡ expressions in both 1:1 and 1:10 co-culture ratio. (A) Flow 
cytometry plots showing percentages of CD11c+ and MHCⅡ+ DC in murine DC co-
cultured with hBM-MSC. (B) Quantification of MHCⅡ expression. Values are the mean 
± SD. ***, p < 0.001 versus LPS treated DC (n=5). ns, not significant. 
 
15. Pro- and anti-inflammatory cytokine changes of co-culture supernatant  
Because the secretion of IL-12p70 is critical for the maturation and function of DCs, it 
was investigated whether BM-MSCs could interfere with IL-12 production by DCs 
including other cytokines. Human BM-MSCs decreased the levels of IL-12p70, TNF-α, 
and IL-6 effectively in both 1:1 and 1:10 co-culture ratio. In contrast, hBM-MSCs 
increased the levels of IL-10 and TGF-β in 1:1 and 1:10 co-culture ratio with DC. 
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Figure 16. Cytokine expressions of DC co-cultured with hBM-MSCs. BM-MSCs 
decreased the levels of IL-12p70, TNF-α, and IL-6 effectively, but increased the levels of 
IL-10 and TGF-β in both 1:1 and 1:10 co-culture ratio. The supernatant from mature DC 
with (1:10 and 1:1) or without (LPS) MSC co-culture were used to quantify the cytokine 
levels in this experiments. (A-C) Expression of pro-inflammatory cytokines including IL-
12p70, IL-4, and TNF-α. (B) Expression of anti-inflammatory cytokines of TGF-β1 and 
IL-10. Values are the mean ± SD. *, p < 0.05; **, p < 0.01; ***, p < 0.001 versus LPS 
treated DC (n=5). 
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16. Gene expressions of anti-inflammatory DC (antiDC) induced by hBM-MSCs  
To explore whether the inhibition of BM-MSCs on DC maturation requires the 
intracellular signal for anti-inflammatory DC, qPCR was used to find important 
regulators or transcription factors which regulates DC status in various co-culture time 
windows. The relative gene expressions of TGF-β1, IL-10, indoleamine 2, 3-
dioxygenase (IDO) and heme oxygenase-1 (HO-1) were highly increased in 1:1 co-
culture ratio at 6 hr. Also, the relative gene expressions of PD-1 ligand 1 (PD-L1) and 
inducible T cell costimulator (ICOS) were significantly increased in 1:1 co-culture ratio. 
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Figure 17. Gene expressions of DC co-cultured with hBM-MSC. The relative gene 
expressions of TGF-β1, IL-10, IDO, HO-1, PD-L1, and ICOS were highly increased in 
1:1 co-culture ratio at 6 hr. DC were isolated from 1:1 co-culture with hBM-MSCs, and 
then the cells were assessed by real time qPCR to determine the anti-inflammation and 
tolerance of DC. Each experiment was conducted in triplicates. Values are the mean ± 
SD. *, p < 0.05 and ***, p < 0.001 versus mature DC as control of each time points 
(n=5). 
 
17. Identification of a unique DC signature co-culture with hBM-MSC 
To identify a unique DC signature at 6 hr co-culture with hBM-MSC, gene profiling of 
DC explored BM-MSCs for 6 hr was performed and quantitative mass spectrometry 
analysis was conducted. Gene array identified almost 10,000 genes that were enriched 
in DC co-cultured with hBM-MSCs (Fig. 18A-B). 228 genes were significantly 
increased and 108 genes were significantly decreased in mature DC (mDC) compared 
to immature DC (iDC). 291 genes were significantly increased and 17 genes were 
decreased in DC co-cultured with hBM-MSCs (antiDC) compared to mDC.  
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Figure 18. Identification of a DC signature co-cultured with hBM-MSCs by gene 
expression and quantitative mass spectrometry. (A) Affymetrix genearray expression 
profile of murine DC identified almost 10,000 genes (> 1.5 fold, p <0.05, Student’s t 
test, two tailed). (B) Scatter plots of gene expression of antiDC. The number means the 
significant correlation between all samples. (C) Heat map of total gene expression of 
antiDC based in hierarchical clustering. Each lane represents the average expression 
value of two biological duplicates per group.  
  
18. Functional gene selection of DC experienced with hBM-MSC 
In biological process, many immune response-regulating signal transduction were 
identified including T cell activation and antigen receptor-mediated signaling and so on 
(Fig.19 A). In cellular component, receptor complex was identified as well T cell 
receptor. In molecular function, nucleotide binding was mostly identified (Fig. 19C). 
 
19. Decreased gene profiles in antiDC versus mDC in comparision to iDC control 
Next, the gene expression was compared between mDC and antiDC for 6 hr. First, up-
regulated genes of mDC were selected compared to iDC under LPS (100 ng/ml) 
treatment, then down-regulated genes of antiDC were chosen compared to mDC 
genearray data. Finally, 102 genes identified that were uniquely expressed in antiDC 
including IL-1α, cxcl10, zbtb32 and lcn2 (Fig. 20, 21). IL-1α also known as 
hematopoietin-1 is responsible for the production of inflammation, maturation of 
dendritic cells. Cxcl10 is a CXC chemokine known to favor the recruitment and 
activation of Th1-polarized cells. BM-MSC reduced the levels of IL-1α and cxcl10 in 
mDC of co-culture condition for 6 hr. 
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Figure 19. Functional categorization of significantly differential expressed genes of 
antiDC experienced hBM-MSCs. (A) Biological process, (B) cellular component, and 
(C) molecular function of antiDC. 
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Figure 20. Hierarchical clustering of dependent and nondependent base changes in gene 
expression; 102 genes whose expression was significantly up-regulated by hBM-MSCs. 
Heat map of total gene expression of antiDC based in hierarchical clustering. Each lane 
represents the average expression value of two biological duplicates per group. 
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Figure 21.Relative gene expressions between three groups, and top 15 gene list of down-
regulated genes of DC-MSC. Kinetics of the expression of genes encoding 
transcriptional regulators down-regulated 1.5-fold or more in antiDC relative to their 
expression in mDC and iDC control. 
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20. Increased gene profiles in antiDC versus mDC in comparision to iDC control 
Then, the other unique gene expression was compared between mDC and antiDC for 6 
hr. First, down-regulated genes of mDC were selected compared to iDC under LPS (100 
ng/ml) treatment, then up-regulated genes of antiDC were chosen compared to mDC 
genearray data. As a results, 20 genes identified that were uniquely expressed in antiDC 
including ccdc80 and Rn18s (Fig. 22, 23). Ccdc 80 (coiled-coil domain containing 80) 
is a protein-coding gene suggesting CCDC80 protein is a peroxiredoxin as ubiquitous 
family of antioxidant enzymes that control cytokine-induced peroxide levels and 
thereby mediate signal transduction in mammalian cells according to bioinformatics 
analysis. BM-MSC reduced ccdc80 level in mDC of co-culture condition for 6 hr. 
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Figure 22. Hierarchical clustering of dependent and nondependent base changes in gene 
expressions; 20 genes whose expression was significantly increased by hBM-MSC. 
Heat map of total gene expression of antiDC based in hierarchical clustering. Results 
were log-transformed, normalized (to the mean expression of zero across samples) and 
centered, and populations and genes were clustered by pairwise centroid linkage with 
the Pearson correlation. Each lane represents the average expression value of two 
biological duplicates per group. 
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Figure 23.Relative gene expression and top 15 gene list of up-regulated genes of DC-
MSC. Kinetics of the expression of genes encoding transcriptional regulators up-
regulated 1.5-fold or more in antiDC relative to their expression in mDC and iDC 
control. 
 
21. Gene profiles in inflammatory responses of antiDC in comparision to iDC and mDC 
To clarify the degree to which regulate the inflammatory responses of DC by hBM-
MSCs, profiling was analyzed using DAVID program that categorizes inflammatory 
responses. Almost 180 gene were identified in innate immune response, also T cell 
tolerance induction was involved in inflammatory response (Fig. 24) 
 
Figure 24. Biological function of antiDC in the category of inflammatory responses.  
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22. Selected gene expression of antiDC co-cultured with hBM-MSCs 
To further characterize antiDC distinguishing from other DC phenotypes, mostly up-
regulated genes of both mDC and antiDC were selected compared to iDC. Also, down-
regulated genes of both mDC and antiDC were selected compared to iDC. Then, RT-
PCR was performed to quantify selected gene expressions. The expressions of Lamb2, 
wars involving regulation of cell cycle and cell proliferation decreased in DC co-
cultured with hBM-MSCs. In addtion, the expressions of ccr7, cxcl4, irf1 involving 
inflammatory response also decreased in DC co-cultured with hBM-MSCs for 6 hr. 
 
 
Figure 25. RT-PCR of antiDC co-cultured with hBM-MSC.RT-PCR analysis of lamb2, 
wars, actb, ccr7, cxcl4, and irf1 expression was decreased in antiDC experienced BM-
MSC for 6 hr. msc, healthy BM-MSC at passage 5 ;6h msc, hBM-MSC alone for 6 hr. 
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23. Function study of antiDC 
To confirm the function of DC co-cultured with hBM-MSCs, DC function study was 
finally performed in triple co-culture system. DC cultured with hBM-MSCs for 6hr at 
first, and CD4+ T cells were added into the co-culturing DC with MSCs for another 72 
hr. BM-MSC increased T cell proliferation compared to immature and mature DC, also 
the expression of FoxP3+ Tregs was increased in DC co-cultured with hBM-MSCs (Fig. 
26).  
 
Figure 26. Function study of antiDC. antiDC proliferated the T cell population, and also 
increased Foxp3+ T cells. (A) Proliferation assay of antiDC assessed by CFSE stained 
CD4+ T cells. (B) Foxp3+ Tregs expression of antiDC by BM-MSCs. CFSE, 
carboxyfluorescein diacetate succinimidyl ester. 
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Ⅳ. DISCUSSION 
In the present study, hBM-MSC significantly increased CD4+FoxP3+PD-1+Tregs 
expression in MSC-CD4 T co-culture condition in in vitro. In addition, gene expression 
of PD-1 was increased in a time dependent manner in 1:5 (MSC: CD4 T) ratio. BM-
MSC significantly increased Nrp-1 gene expression at 24hr, and decreased CTLA-4 and 
Lag-3 gene expressions in a time dependent manner. BM-MSC significantly increased 
protein expressions of FoxP3, Nrp-1, and PD-1 in MSC-CD4 T co-culture condition, 
and also increased the immunopositivity of PD-1 on T cells in inflamed tissue of CIA 
mice treated with hBM-MSCs.  
Tregs induction when co-cultured with hBM-MSCs was consistent with our previous 
findings that induced CD4+Foxp3+ Tregs in CIA mice in vivo12. Tregs play a crucial role 
in controlling autoimmunity by inducing tolerance, and they prevent the development 
of chronic inflammatory and autoimmune diseases16. FoxP3 is a master transcription 
factor specific to Treg cells and supports their differentiation and functions16. In vitro 
and in vivo studies with human, baboon, and murine MSCs demonstrated that MSCs 
suppress the proliferation of T cells induced by alloantigens or mitogens, and induce 
Foxp3+ Tregs, which are pivotal to maintaining self-tolerance and preventing 
autoimmunity12,18,19. However, the mechanisms of Foxp3+ Tregs induced by hBM-MSC 
are derived from naturally occurring thymus-derived Tregs (nTregs) or peripherally 
induced Tregs (iTregs) that develop from naive T cells under different conditions are 
not well defined that the origins and signalings.  
In addition to CD25 and Foxp3, Treg cells express various surface molecules, such as 
CD28/cytotoxic T lymphocyte antigen 4 (CTLA-4), lymphocyte activation gene-3 (LAG-
3), Neorupilin-1 (Nrp-1), and programmed death-1 (PD-1), on the cell surface or in the 
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intracellular region. These molecules expressed by Treg cells might have profound effects 
on the suppressive function of Treg cells16-21. Also, CTLA-4, LAG-3, and PD-1, are also 
highly upregulated on exhausted T cells, and they mediate the inhibition of pathogen-
specific T cell function19,20. Among the various inhibitory receptors, PD-1 is a hallmark 
of exhausted T cells in chronic pathogen infection19,20. In the present study, BM-MSCs 
increased PD-1 expression of CD4+ T cells when the Foxp3+ Tregs induced by BM-MSCs 
in in vitro. PD-1 is an immuonoreceptor belonging to CTLA-4 family, provides negative 
costimulation to antigen stimulation, and play a critical role in Foxp3+Tregs induction21. 
In this study, Foxp3+ Tregs did not increased when co-cultured with BM-MSC and CD4+ 
T cells from PD-1 knockout mice. PD-1 may play an important role in Foxp3+ Tregs 
induction in vitro.  
Nrp-1 is a cell surface molecule that can be efficiently used to separate inducible versus 
nTregs subsets, and nearly 70% of Foxp3+ T reg cells expressed Nrp-1 in WT NOD or 
B6 mice22,23 suggesting marker of nTregs because of high levels on nTregs cells23. In 
the present study, the expression of Nrp-1 was significantly increased at 24 hr earlier 
than that of PD-1 in CD4+ T cells co-cultured with hBM-MSCs even though in vitro 
experiment. However, Nrp-1 that is proper Tregs marker of natural or induced Tregs is 
now controversial in distinct immune settings. Therefore, the roles of PD-1 and Nrp-1 
in Foxp3+ Tregs induction need to be further determined. 
The polyclonal activation of T cells in Ctla4 knockout mice is most likely a result of the 
dysfunction of Treg cells, and deletion of the CTLA-4 gene in FoxP3+ Treg cells 
recapitulated the fatal disease of the Ctla4 knockout mice24. Thus, CTLA-4 might be 
related to Tregs induction recently. Also, LAG-3 was recently reported to negatively 
regulate the function of CD4+ T cells, CD8+ T cells, and plasmacytoid DCs and to 
regulate the homeostatic proliferation of CD8+ T cells and the suppressive activity of T 
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reg cells20. However, the effect of LAG-3 in these assays is relatively small, and the 
actual contribution of LAG-3 to the regulation of immune system has been unclear. In 
the current study, the expressions of CTLA-4 and LAG-3 were not significantly changed 
by hBM-MSC, and the roles of these two inhibitory immunoreceptors that induce 
Foxp3+ Tregs under experiencing MSCs will be elucidated.  
It is well known that MSCs exert profound immunosuppressive properties on T cell 
proliferation. However, their effect on the initiators of the immune response, the DCs 
are relatively unknown. DCs play an important role in the initiation of primary 
immune responses and in the induction of tolerance, depending on their stage of 
activation and maturation. In this present study, hBM-MSCs significantly inhibited the 
DCs maturation by decreasing CD86 and MHCⅡ expressions in both 1:1 and 1:10 
co-culture ratio. Human BM-MSCs also decreased the levels of IL-12p70, TNF-α, and 
IL-6 effectively in both 1:1 and 1:10 co-culture ratio. And, BM-MSCs increased the 
levels of IL-10 and TGF-β in 1:1 and 1:10 ratio. The gene expressions of IDO, HO-1, 
PD-L1 and ICOS which explored BM-MSCs for 6 hr were increased in 1:1 co-culture 
ratio.  
IDO is a catabolitic enzymes that degrades the essential amino acid tryptophan (trp), 
which can suppress T cell proliferation by producing metabolic products including 
kynurenine. The potential role of IDO in immune suppression first gained attention 
because of its involvement in Treg induction25. Recently, as well as DC tolerance, the 
induction of Tregs have shown to increase the IDO expression or activity in vitro and 
in vivo24. HO-1 is a microsomal enzyme with antioxidant, antiapoptotic, and 
immunoregulatory functions in the degradation of heme to biliverdin, carbon 
monoxide, and iron26. Recently, it is also involved in immune regulation and anti-
inflammation through a single reported clinical case of HO-1 deficiency show that a 
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systemic lack of HO-1 results in profound immune dysregulation, characterized by a 
number of autoimmune lesions. HO-1 plays a role in the active inhibition of T cell 
responses by inducing tolerogenic DCs27. In the present study, gene expressions both 
IDO and HO-1 were significantly increased in DC co-cultured with BM-MSCs 
suggesting that the involvement of IDO and HO-1 on immunomodulatory function of 
BM-MSCs against DC maturation. 
ICOS is critical in the regulation of humoral response, and has also been linked with 
Treg maintenance in mice and mucosal tolerance28. In human ICOS plays a 
predominant role in pDC/T-cell interaction and participates in naive CD4+ T cell 
polarization into IL-10-secreting Tr1-like cells. ICOS was also associated with Treg 
homeostasis in nonobese diabetic (NOD) mice and with increased Treg proliferative 
capacity and immunosuppressive functions. In the present study, the gene expression 
of ICOS was significantly increased in DC co-cultured with BM-MSCs suggesting 
that the involvement of ICOS on anti-inflammatory DC functions after experiencing 
BM-MSCs.  
PD-L1 is found on resting T cells, B cells, macrophages, and dendritic cells, a negative 
regulatory pathway that results in T-cell exhaustion. PD-1: PD-L signaling also plays 
an important role in the maintenance of peripheral cell tolerance and the generation of 
induced regulatory T cells29. The PD-1–PD-L1 pathway exerts its effects during the 
initial phase of activation and expansion of autoreactive T cells by attenuating self-
reactive T cell responses during presentation of self-antigen by DCs. 
Treg cells also upregulate PD-1 expression on their surfaces during chronic viral 
infection29. PD-1: PD-L1 interaction has a critical role in promoting the conversion of 
conventional T cells into Treg cells and maintaining them. In this study, the expression 
of PD-L1 was highly increased in DC co-cultured with BM-MSCs suggesting that the 
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pivotal role of PD-L1 to induce tolerance and Tregs. 
This is first reports that show total gene expressions of DC co-cultured with hBM-
MSCs assessed by microarray. Also, a unique genetic signature of DC co-cultured 
with BM-MSCs was identified that distinguish from classical DC and other DC 
subsets using various approaches. Many biological functions involved the immune 
modulation of BM-MSCs on DC, of course, including inflammatory responses. 
Despite of new features of DC explored MSCs, the genuine function of DC maintained 
under co-culture condition. Detailed regulations and functions of selected genes will 
be required to determine the extent to which major factor alter DC differentiation and 
to define which factors might be a good marker for regulatory DC. 
In vitro studies with human, baboon, and murine MSCs demonstrated that MSCs 
suppress the proliferation of T cells induced by alloantigens or mitogens.  
Furthermore, MSCs have been reported to induce T cell division arrest, to inhibit the 
differentiation and maturation of dendritic cells (DCs), and to decrease the production 
of inflammatory cytokines by various immune cell populations. Several factors and 
molecules secreted by MSCs have been linked to the immunoregulatory function of 
these cells30. These include TGF-β, NO, IDO, TSG6, prostaglandin E2, IL-1 receptor 
antagonist, IL-10 and an antagonistic variant of the chemokine CCL2. Also, several 
studies have examined their direct effects on T cells by determining how MSCs affect 
proliferation, apoptosis, differentiation and regulatory mechanisms in T cells, 
including the induction of Treg cells mediated by iNOS or IDO30. Therefore, further 
studies need to be investigating the immune modulatory mechanism of MSCs from a 
perspective of the direct effects on other immune cells or their secretomes. 
In this present study, human BM-MSCs and murine DC or CD4+ T cells were co-
cultured to explain the innunosuppressive functions of MSCs in in vitro. According to 
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previous published data, MSCs are not rejected by the immune system, even after 
allogenic or xenogenic transplantation5,6,12, because T-cells do not recognize them. 
They express few or no class II MHC molecules or costimulation molecules, such as 
CD80 and CD861-3. Nevertheless, the mechanism study using co-culture system of 
hBM-MSC and human DC or CD4+ T cells needs to be further investigated.   
According to data, human BM-MSCs significantly increased Foxp3+Tregs in co-
culture with CD4+ T cells in vitro. The cells decreased pro-inflammatory cytokines 
and up-regulated anti-inflammatory cytokines and induced PD-1+ Tregs. These results 
show that the immune modulatory effect of MSCs was associated with Tregs induction, 
consistent with the increase in anti-inflammatory cytokine expression. In addition, 
human BM-MSCs significantly suppressed the maturation of DC, and increased the 
anti-inflammatory cytokines and tolerogenic genes relating to increase of anti-
inflammatory and regulatory DC in peripheral tissues under inflammatory condition. 
Therefore, these findings provide evidences into the mechanisms of Foxp3+ Treg 
induction, and new insights into anti-inflammatory and regulatory DC functions.  
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Ⅴ. CONCLUSION 
 
These data showed that human BM-MSCs inhibit the maturation of DCs and induce 
anti-inflammatory signals of DCs in in vitro. Moreover, our data showed that human 
BM-MSCs induced the CD4+Foxp3+ Tregs in both in vitro and in vivo. 
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Abstract (in Korean) 
 
콜라겐 유도 관절염 마우스 모델에서 
T 세포와 수지상세포에 대한 중간엽줄기세포의 
면역조절 및 항염증 기전 규명 
 
<지도교수 박 용 범> 
 
연세대학교 대학원 의과학과 
 
문 진 희 
 
중간엽줄기세포는 면역조절능을 가진 줄기세포로, 이를 이용한 세포치료가 
많은 염증성 질환 모델에서 연구되고 있다. 중간엽줄기세포의 면역조절능은 
면역세포의 증식과 활성화를 저해하는 것과 관련되어 있다. 수지상세포는 
선천 면역반응을 매개하는 중요한 면역세포로 항원전달기능을 가지고 있다. 
수지상세포는 염증성 수지상세포로 성숙할 수 있고 이는 후천면역반응을 
일어나게 한다. T 세포는 Th1, Th2, Th17 또는 조절 T 세포로 분화할 수 
있으며, 항원전달세포의 신호를 받아 후천면역반응을 조절하는 중요한 
면역세포이다. 본 연구는 중간엽줄기세포가 가진 수지상세포와 T 세포에 
대한 면역조절능 및 그 기전에 대해 연구하였다. 
DBA/1 마우스의 비장에서 CD11C 양성 수지상세포를 분리하여 GM-CSF와 
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IL-4 처리하여 7일 간 미성숙 수지상세포로 분화하였다. CD4 양성 T 세포는 
CD4 양성 T 세포 분리키트를 이용하였다. 다양한 공배양 비율로 
수지상세포와 T 세포 각각 인간 골수 유래 중간엽줄기세포와 공배양하였다. 
수지상세포의 성숙 및 T 세포 분화에 대한 중간엽줄기세포의 영향은 flow 
cytometry로 확인하였고, 공배양 상층액에서 사이토카인의 발현을 
확인하였다. 유전자 발현은 qRT-PCR 및 microarray로 확인하였으며, 콜라겐 
유도 관절염 마우스 모델에서 조직학적 염색을 시행하였다. 
중간엽줄기세포와 공배양한 조건에서 CD4+CD25+FoxP3+조절 T 세포의 
발현이 높게 증가하였다. 또한, 중간엽줄기세포는 PD-1, Nrp-1 유전자 발현 
역시 증가시켰다. 항염증성 사이토카인인 IL-10, TGF-β의 발현 또한 
증가하였으며, 중간엽줄기세포를 처치한 콜라겐 유도 관절염 마우스 모델의 
발 조직에서 PD-1의 발현이 증가하였다. 
골수 유래 중간엽줄기세포는 1:1 및 1:10 공배양 조건에서 CD86 및 
MHCⅡ의 발현을 감소시킴으로써 수지상세포의 성숙을 저해하였다. 또한, 
염증성 사이토카인인 IL-12p70, TNF-α, IL-6의 발현을 감소시키고, 항염증성 
사이토카인인 IL-10, TGF-β의 발현은 증가시켰다. 또한, 1:1 비율에서 6시간 
동안 중간엽줄기세포와 공배양한 수지상세포에서 IDO, HO-1 유전자발현이 
증가하였다.  
본 연구를 통하여 골수 유래 중간엽줄기세포가 수지상세포의 성숙을 
억제할 뿐만 아니라, 염증성 수지상세포를 항염증성 수지상세포로 유도함을 
증명하였다. 또한, 골수 유래 중간엽줄기세포는 세포 공배양 및 동물 모델 
연구를 통해 CD4+CD25+FoxP3+ 조절 T 세포 발현을 증가시켰다.  
--------------------------------------------------------------------------------------------------------
핵심되는 말: 중간엽줄기세포, 면역조절, 수지상세포, 조절 T 세포  
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